Publication Details

Pubmed31447003
Title: Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma.
Year: 2019
DOI: https://doi.org/10.1016/j.lungcan.2019.07.011
First Author: Morra
Experimental setup: affinity chromatography technology (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
CCDC6_HUMANBAP1_HUMANBioGRIDdetails